Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

OCEL

Organicell Regenerative ... (QB) (OCEL)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:OCEL
DataOraFonteTitoloSimboloCompagnia
27/11/202323:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
19/10/202312:56Edgar (US Regulatory)Form PRER14C - Information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
28/09/202320:54Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/09/202322:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
25/08/202321:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/08/202322:34Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
11/07/202322:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
29/06/202315:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
28/06/202322:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
16/06/202322:07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/06/202322:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
09/06/202322:36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/02/202322:59Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/02/202322:39Edgar (US Regulatory)Annual Report (10-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
30/12/202219:46Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
17/11/202214:38InvestorsHub NewsWireOrganicell Starts Enrolling Long COVID TrialUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
15/11/202214:52InvestorsHub NewsWireOrganicell Activates COPD Trial at Mayo ClinicUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
03/11/202222:02Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
20/10/202223:10Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
30/12/202122:14Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
21/07/201520:17Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
21/05/201520:38Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
19/09/201307:04OTC MarketsOcean Electric, Inc. (OCELE: OTCQB) | Symbol ChangeUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
18/09/201306:00OTC MarketsTier ChangeUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/08/201312:00Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
05/06/201312:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
02/04/201312:13Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
10/01/201320:02Edgar (US Regulatory)Current report filing (8-K)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
08/01/201322:12Edgar (US Regulatory)Amended Current report filing (8-K/A)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
08/01/201322:12Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:OCEL
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network